Role of estrogen receptors in the vascular system

• Published in: Vascular pharmacology 2002-02, Vol.38 (2), p.81-88
• Main Authors: Rubanyi, Gabor M, Kauser, Katalin, Johns, Anthony
• Format: Article
• Language: English
• Subjects: Angiogenesis; Animals; Atherosclerosis; Cardiovascular Diseases - drug therapy; Cardiovascular Diseases - genetics; Cardiovascular Diseases - metabolism; Cardiovascular System - metabolism; Coronary artery disease; Endothelium; Endothelium, Vascular - drug effects; Endothelium, Vascular - metabolism; Estradiol - pharmacology; Estradiol - therapeutic use; Humans; Nitric oxide; Receptors, Estrogen - genetics; Receptors, Estrogen - physiology; Vascular smooth muscle
• ISSN: 1537-1891; 1879-3649
• DOI: 10.1016/S0306-3623(02)00130-1

Estrogens have been shown to exert significant benefits on the cardiovascular system both in animals and in postmenopausal women. However, the exact mechanism of these effects are, for the most part, still unknown. The goal of this paper is to evaluate the role of estrogen receptors (ER) in mediating some of the cardiovascular beneficial actions of 17β-estradiol (E2). This analysis was possible because of the availability of ERα (ERαKO) and ERβ-deficient (ERβKO) mice, and access to a patient with ERα-deficiency. Experimental results obtained in our laboratory demonstrated that the ERα subtype mediates E2-induced increase in endothelial nitric oxide production and facilitation of fibroblast growth factor-elicited angiogenesis in vivo. Others have confirmed these findings. Experiments using a novel ER-antagonist and ApoExERα double-knockout mice proved that ERα mediates some of the antiatherosclerotic effects of E2 as well. In contrast, both the ERα and ERβ subtypes appear to mediate the beneficial effects of E2 on vascular smooth muscle proliferation after vessel injury. The young male patient with ERα-deficiency exhibited reduced endothelial nitric oxide production and premature coronary arteriosclerosis. These studies in mice and a male human subject suggest that absence of functional ER may represent a novel risk factor for cardiovascular diseases.